OVARY-I by Rejiv Rejindranath
Session 2 : OVARY-I
"Bevacizumab after bevacizumab in platinum sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213"
chemotherapy in ovarian, fallopian tube, and peritoneal carcinoma NCI-supplied agent(s): A GOG/NRG trial (GOG 252) NCT01167712 a GOG/NRG trial (gog 252). Presented at: 2016 SGO Annual Meeting. March 19-22, 2016. San Diego, CA